Aner geschützt Aminosaieren fir Bléck Bond
Promrat Detail
| NO | Produkter vun Produkter | Cas Nee | D'Applikatioun | Schlësselqualitéit Indikator | ||||
| Rengheet | Isomer | Spezifesch Impuritéit | * Max1 | Fiichtegkeet | ||||
| 1 | Fmoc-cys (Acm) -oh | 86060-81-3 | Disulfide Bond | ≥990% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1.0% |
| 2 | Fmoc-cys (MMT) -oh | 177582-21-7 | Disulfide Bond | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 3 | Fmoc-Cys (4-Allylbutyrat) -oh | / | Disulfide Bond | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 4 | MPA (TT) -OH | 27144-18-9 | Enn vun der Sequenz | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 5 | Fmoc-thr (tbu) -ol | 189337-28-8 | Octreotide | ≥97.0% | ≤0,3% | ≤0,5% | ≤1.0% | ≤1.0% |
| 6 | Fmoc-D-arg (PBF) -oh | 187618-60-6 | Desmopressin | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤2.0% |
| 7 | Fmoc-gly-gly-oh | 35665-38-4 | Bivalirudin | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 8 | Fmoc-gly-gly-gly-oh | 170941-79-4 | Terlipressin | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 9 | Fmoc-gly-gly-gly-gly-oh | / | Bivalirudin | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 10 | Fmoc-gly-ASP (TBU) -Oh | / | Bivalirudin | ≥99,5% | / | ≤0,15% | ≤0,2% | ≤1.0% |
| 11 | Boc-Cys (Ttr) -oh | 21947-98-8 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 12 | Boc-arg (pbf) -oh | 200124-22-7 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 13 | Boc-Ala-oh | 15761-38-3 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 14 | Boc-D-phe-oh | 18942-49-9 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 15 | Boc-gly-oh | 4530-20-5 | Enn vun der Sequenz | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 16 | Boc-Lys (Boc) -oh.dcha | 15098-69-8 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 17 | Boc-ser (tbu) -oh | 7738-22-9 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 18 | Boc-thr (tbu) -oh | 13734-40-2 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 19 | Boc-D-Ala-Oh | 7764-95-6 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 20 | Boc-met-oh | 2488-15-5 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 21 | Boc-Tyr (tbu) -oh | 47375-34-8 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 22 | Boc-d-arg (pdf) -oh | 187618-60-6 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 23 | Boc-ASP (OTBU) -Oh.dcha | 1913/12/8 | Enn vun der Sequenz | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 24 | Fmoc-Homorarg (PBF) -oh | 1159680-21-3 | Elattifibatide | ≥98,5% | ≤0,2% | / | ≤0,5% | ≤2.0% |
| 25 | FMOC-ASP-OTBU | 129460-09-9 | Thymalfasin | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1.0% |
| 26 | Fmoc-tyr (mech) -oh | 77128-72-4 | Carbingtocin | ≥98,5% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 27 | Fmoc-orn (Boc) -oh | 109425-55-0 | Atosiban Omnipressin DAPTOMYCIN | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤2.0% |
| 28 | Fmoc-d-tyr (et) -oh | 162502-65-0 | Atosiban | ≥99,5% | ≤0,1% | ≤0,1% | ≤0,2% | ≤1.0% |
| 29 | Fmoc-ASP (Oall) -oh | 146982-24-3 | Melanotan | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 30 | Ac-nle-oh | 15891-49-3 | Melanotan | ≥990% | / | ≤0,3% | ≤0,3% | ≤1.0% |
| 31 | Fmoc-nle-oh | 77284-32-3 | Melanotan Afamellanotide | ≥990% | / | ≤0,3% | ≤0,3% | ≤1.0% |
| 32 | Ac-Glu (Otbu) -oh | 84192-88-1 | Aarssereine ACTYL Octapeptide-3 | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 33 | Ac-β-Ala-oh · Dcha | / | Acetyl tetrapeptide-5 | ≥990% | / | ≤0,3% | ≤0,3% | ≤1.0% |
| 34 | Fmoc-ß-ali-oh | 35737-10-1 | Acetyl tetrapeptide-5 | ≥99,5% | / | ≤0,1% | ≤0,2% | ≤1.0% |
| 35 | FMOC-HYP (TBU) -OH | 122996-47-8 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 36 | Fmoc-thi-oh | 130309-35-2 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 37 | Fmoc-d-tich-oh | 130309-33-0 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 38 | Fmoc-oic-oh | 130309-37-4 | Icatibant | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 39 | BOC-SAR-OH | 13734-36-6 | Saalasin | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 40 | Fmoc-sar-oh | 77128-70-2 | Saalasin | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 41 | Fmoc-Tyr (so3na) -oh.h2o | 106864-37-3 | Gesond | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 42 | Fmoc-D-ASP (OTBU) -Oh | 112883-39-3 | DAPTOMYCIN | ≥98,5% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 43 | AC-SER (TBU) -OH | 77285-09-7 | Afamellanotide | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
| 44 | Boc-homocys (trt) -oh | 201419-16-1 | Deprimide | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 45 | Fmoc-Homocys (Ttr) -oh | 167015-23-8 | Deprimide | ≥98,0% | ≤0,2% | ≤0,3% | ≤0,5% | ≤1.0% |
| 46 | Fmoc-dab-oh | 161420-87-7 | Schlaang venom | ≥990% | ≤0,2% | ≤0,3% | ≤0,3% | ≤1.0% |
* Max1 = Max onbekannte Rengheet
Aner Indikator:
- Essigsäure: ≤0.02% (all Produkter)
- Ethyl Acetate: ≤0,5% (all Produkter)
- Alkohol: ≤0,5% (all Produkter)
- Max onbekannte Gegrëff: FMOC-TRP (Boc) -oh (143824-78-6) ≤.3%; Anerer ≤0,2%
